Literature DB >> 33206669

Factors associated with successful completion of outpatient parenteral antibiotic therapy in an area with a high prevalence of multidrug-resistant bacteria: 30-day hospital admission and mortality rates.

Thais Cristina Garbelini Salles1,2, Santiago Grau Cerrato3, Tatiana Fiscina Santana4, Eduardo Alexandrino Medeiros1.   

Abstract

OBJECTIVES: To identify factors associated with hospital admission and mortality within the first 30 days after enrolment in an outpatient parenteral antimicrobial therapy (OPAT) program, also analysing adequacy of the treatment regimen and clinical outcomes. PATIENTS AND METHODS: This was a retrospective cohort study conducted between October 2016 and June 2017 in the state of São Paulo, Brazil. Variables related to hospital admission and mortality were subjected to bivariate analysis, and those with a P<0.05 were subjected to multivariate analysis as risk factors.
RESULTS: We evaluated 276 patients, of whom 80.5% were ≥60 years of age and 69.9% had more than one comorbidity. Of the patients evaluated, 41.3% had pneumonia and 35.1% had a urinary tract infection. The most common etiological agent, isolated in 18 (31.6%) cases, was Klebsiella pneumoniae, and 13 (72,2%) strains were carbapenem resistant. The OPAT was in accordance with the culture results in 76.6% of the cases and with the institutional protocols in 76.4%. The majority (64.5%) of the patients were not admitted, and a cure or clinical improvement was achieved in 78.6%. Multivariate analysis showed that, within the first 30 days after enrolment, the absence of a physician office visit was a predictor of hospital admission (P<0.001) and mortality (P = 0.006).
CONCLUSIONS: This study demonstrated the viability of OPAT in elderly patients with pulmonary or urinary tract infections in an area with a high prevalence of multidrug-resistant bacteria and that a post-discharge physician office visit is protective against hospital admission and mortality.

Entities:  

Year:  2020        PMID: 33206669      PMCID: PMC7673565          DOI: 10.1371/journal.pone.0241595

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  23 in total

1.  Management of endocarditis: outpatient parenteral antibiotic treatment in Argentina.

Authors:  G Lopardo
Journal:  Chemotherapy       Date:  2001       Impact factor: 2.544

Review 2.  Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade.

Authors:  Michael MacKenzie; Nikolas Rae; Dilip Nathwani
Journal:  Int J Antimicrob Agents       Date:  2013-10-14       Impact factor: 5.283

Review 3.  Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review.

Authors:  Annarita Mazzariol; Alda Bazaj; Giuseppe Cornaglia
Journal:  J Chemother       Date:  2017-12       Impact factor: 1.714

Review 4.  The global epidemiology of carbapenemase-producing Enterobacteriaceae.

Authors:  David van Duin; Yohei Doi
Journal:  Virulence       Date:  2016-08-11       Impact factor: 5.882

5.  Early Infectious Disease Outpatient Follow-up of Outpatient Parenteral Antimicrobial Therapy Patients Reduces 30-Day Readmission.

Authors:  Ena Saini; Mohammad Ali; Ping Du; Tonya Crook; John Zurlo
Journal:  Clin Infect Dis       Date:  2019-08-16       Impact factor: 9.079

6.  Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system.

Authors:  Eliane Molina Psaltikidis; Everton Nunes da Silva; Maria Luiza Moretti; Plínio Trabasso; Raquel Silveira Bello Stucchi; Francisco Hideo Aoki; Luís Gustavo de Oliveira Cardoso; Christian Cruz Höfling; Luis Felipe Bachur; Danilo da Fontoura Ponchet; Maria Rosa Ceccato Colombrini; Cíntia Soarez Tozzi; Rosana Fins Ramos; Sandra Mara Queiroz Costa; Mariângela Ribeiro Resende
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2018-11-05       Impact factor: 2.217

7.  Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: Systematic review and meta-analysis: Mortality due to KPC Klebsiella pneumoniae infections.

Authors:  Jorge A Ramos-Castañeda; Alberto Ruano-Ravina; Raquel Barbosa-Lorenzo; Jaime E Paillier-Gonzalez; Javier C Saldaña-Campos; Diego F Salinas; Elkin V Lemos-Luengas
Journal:  J Infect       Date:  2018-03-01       Impact factor: 6.072

8.  [Evaluation of the effectiveness, safety and costs of outpatient intravenous antimicrobial treatment (OPAT) vs hospitalized in urinary infection in pediatrics].

Authors:  Anamaría Peña; Alexsandra Zambrano; Muriel Alvarado; Jaime Cerda; Rodrigo Vergara
Journal:  Rev Chilena Infectol       Date:  2013-08       Impact factor: 0.520

9.  Outpatient parenteral antimicrobial therapy for orthopedic infections - a successful public healthcare experience in Brazil.

Authors:  Priscila Rosalba Oliveira; Cassia da Silva Felix; Vladimir Cordeiro de Carvalho; Arlete Mazzini Giovani; Rosangela Suarti Dos Reis; Marisa Beraldo; Edmir Peralta Albuquerque; Walter Cintra Ferreira; Jorge Dos Santos Silva; Ana Lucia Lei Lima
Journal:  Braz J Infect Dis       Date:  2016-04-18       Impact factor: 3.257

10.  Outpatient ertapenem therapy in an ESBL-high-prevalence area: an efficacy, safety, and cost study.

Authors:  Arturo Ortiz-Álvarez; Mónica A Delgado-Ramírez; Montserrat Cuevas-Zúñiga; Teresa Hernández-Carrera; David Moncada Barrón; Daniel Aguilar Zapata; Rafael R Valdez Vázquez; Juan Pablo Ramírez-Hinojosa; Ana Patricia Rodríguez-Zulueta
Journal:  Infect Drug Resist       Date:  2018-12-28       Impact factor: 4.003

View more
  1 in total

Review 1.  Treatment of infections caused by multi-resistant microorganisms in hospital at home units.

Authors:  M Mirón-Rubio
Journal:  Rev Esp Quimioter       Date:  2021-09-30       Impact factor: 1.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.